Phase 3_Trastuzumab Deruxtecan T-DXd; DS-8201a_HER2-positiveBreastCancer_DS8201-A-U305NSABP B-60

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date7/30/21 → …